Trademark Overview
On Saturday, May 9, 2026, a trademark application was filed for CEIZBAT with the United States Patent and Trademark Office. The USPTO has given the CEIZBAT trademark a serial number of 99813047. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Saturday, May 9, 2026. This trademark is owned by Shanghai Aucta Pharmaceuticals Co., Ltd.. The CEIZBAT trademark is filed in the Pharmaceutical Products category with the following description:
Ophthalmologic preparations; Allergy medication; Pharmaceutical preparations, namely, appetite suppressants; Bronchodilators; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Anti-diabetic pharmaceuticals; Anti-epileptic pharmaceutical preparations; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical agents affecting metabolism; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical preparations for treating allergic rhinitis and as...
